We are delighted to welcome David R. Liu, Ph.D. to lead our fireside chat at this year’s #Science2Startup symposium in Cambridge, MA on April 10th. Liu is the Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of MIT and Harvard; Thomas Dudley Cabot Professor of the Natural Sciences & Professor of Chemistry and Chemical Biology at Harvard University; and Howard Hughes Medical Institute Investigator. His major research interests include the engineering, evolution, and in vivo delivery of genome editing agents to study and treat genetic diseases; the evolution of novel therapeutic proteins using phage-assisted continuous evolution (PACE); and the discovery of bioactive synthetic molecules using DNA-templated organic synthesis and DNA-encoded libraries. As a business leader, he has successfully launched, led and scaled companies and products in the #healthcare space. Learn more about Science2Startup, a unique event where entrepreneurs and researchers in the biotech space can meet, collaborate, and learn from one another: www.science2startup.com If you'd like to get involved, email us at: info@science2startup.com
RA Capital Management’s Post
More Relevant Posts
-
🎉 Exciting Milestone Alert: BioInCRO LTD is Officially Incorporated! 🎉 We're thrilled to share a monumental milestone in our journey - BioInCRO LTD is now officially incorporated as a private limited company under the Companies Act 2006! 🚀 Company Number: 15518095 This marks a significant step forward in our mission to revolutionize the field of bioinformatics and computational biology. With our incorporation, we're not just a team of passionate innovators; we're a recognized entity ready to make even greater strides in scientific research and development. Here's What This Means for Us: Strengthened Foundation: Our official status solidifies our commitment to advancing bioinformatics research and solutions. Enhanced Opportunities: As a private limited company, we're poised to explore new partnerships, expand our services, and engage with a broader community of scientists, researchers, and industry leaders. Continued Innovation: With our registered office in England and Wales, we're excited to contribute to the vibrant scientific ecosystem, driving forward discoveries that impact global health and knowledge. A Heartfelt Thank You None of this would be possible without the incredible support of our team, partners, and the community that believes in our vision. Your encouragement fuels our dedication to pushing the boundaries of what's possible. The Future is Bright As we embark on this new chapter, we're filled with gratitude and excitement for what lies ahead. Here's to continued innovation, collaboration, and discovery that shapes the future of bioinformatics and computational biology. Stay tuned for updates on our projects, breakthroughs, and the difference we're making together. The journey is just getting started, and we can't wait to share every milestone with you. www.bioincro.com #BioInCRO #Incorporation #Milestone #Bioinformatics #ComputationalBiology #Innovation #ScienceAndTechnology
To view or add a comment, sign in
-
This is a great article about the SPARK program featured in the February 2024 issue of Nature Portfolio's Biotechnology. The incredibly successful SPARK model was developed by SPARK at Stanford and has been adopted by over 60 universities in 6 continents, including the University of Vermont's SPARK-VT. "Over the past 17 years, SPARK at Stanford has a ~50% success rate as measured by two criteria: advancing projects through licensing to commercial entities and/or entering into investigator-initiated clinical studies.” Check out the full story below and learn more about the SPARK approach to translation research. (https://lnkd.in/ghgQjfWP) #SPARK #Technology #Innovation #UVM #Research
To view or add a comment, sign in
-
Visiting Grad Student Researcher at Harvard | Biomedical, Mechanical & Electrical Engineering | Political Speaker
Embarking on the journey from discovering drugs to obtaining FDA approval is a significant challenge, often requiring a massive investment of over 3 billion dollars. As we navigate this complex path, traditional in-vitro studies fall short, struggling to capture the intricacies of the human body. Animal studies, while time-consuming and expensive, are also inaccurate and raise ethical concerns. Now, envision this: a small, chip-like platform intricately designed to model entire organs, including different cell types and tissues, even simulating mechanical forces. Researchers at the Wyss Institute at Harvard University create microenvironments that go beyond providing a glimpse—they dynamically simulate organ behavior. These platforms can imitate the functions of healthy organs, allowing us to understand their physiology. Alternatively, they can replicate disease conditions, unlocking insights and exploring potential therapies. In the esteemed halls of the Wyss Institute, I am captivated by the revolutionary potential of Organ-on-a-Chip technology. Throughout my research stay at Harvard University / Harvard Medical School, following my transition from Leibniz Universität Hannover I am enthusiastic about contributing to a field that has the potential to reshape drug development and medical research. What's even more captivating is the prospect of connecting different organ-chips, forming a symphony—a Human-on-a-Chip. Imagine using a patient's cells to predict their unique reactions to various medications with unprecedented precision. It's not just a technological leap; it's a paradigm shift, revolutionizing our approach to human health. #organoids #organchip #harvard #bioengineering #geneticengineering #biosensors #thesis #biotech #medtech #boston
To view or add a comment, sign in
-
Vice President Technology & Operations, Carbonova Corp | People-Focused Leader and Collaborator | R&D to Technology Commercialization | Champion for Diversity, Equality & Inclusion
Leave it to Stanford University to figure this out. "Begin with the end in mind" will be familiar to the many, many people in industry who have taken 7-Habits training. It's an important mindset when launching a project. SPARK at Stanford / SPARK Alberta is applied to the biotechnology field, but could be easily translatable to other sectors (e.g. decarbonization of heavy industry). It also represents potential for substantial augmentation of traditional tri-council (Natural Sciences and Engineering Research Council of Canada (NSERC), SSHRC-CRSH, Canadian Institutes of Health Research | Instituts de recherche en santé du Canada) funding for Canadian universities and creating industry linkages that could bridge the gap in R&D uptake by the private sector in Canada, which has been well documented recently. I would argue the SPARK model could be made even more impactful if universities were to hire more people with industry experience into formal leadership roles, as opposed to only those whose careers follow the more traditional academic trajectory.
This is a great article about the SPARK program featured in the February 2024 issue of Nature Portfolio's Biotechnology. The incredibly successful SPARK model was developed by SPARK at Stanford and has been adopted by over 60 universities in 6 continents, including the University of Vermont's SPARK-VT. "Over the past 17 years, SPARK at Stanford has a ~50% success rate as measured by two criteria: advancing projects through licensing to commercial entities and/or entering into investigator-initiated clinical studies.” Check out the full story below and learn more about the SPARK approach to translation research. (https://lnkd.in/ghgQjfWP) #SPARK #Technology #Innovation #UVM #Research
To view or add a comment, sign in
-
Technology focus issue out now 👉 https://lnkd.in/dta7CF2Z Continuing the #50YearsofCell celebrations, we're now highlighting impactful technologies that not only revolutionize our understanding of biology or disease but also increase the number of people who can participate in and benefit from the forefront of research. In this issue, you’ll find reviews on technologies ranging from spatiotemporal omics to eDNA and perspectives from researchers in a wide variety of fields, including a Voices article, co-published by Trends in Biotechnology and Cell by Cell Press on in vitro human cell-based models.
To view or add a comment, sign in
-
🚀 Exciting News from BioInCRO! 🚀 At BioInCRO, we are passionate about accelerating scientific discovery and innovation. We understand the complexities and challenges that come with bioinformatics projects. That's why we are thrilled to announce a for researchers and organizations! 🌟 Get a FREE Consultation for your bioinformatics project! 🌟 Whether you're tackling genomic data analysis, proteomics, or any area of computational biology, our team of experts is here to provide guidance, optimize your workflows, and help you overcome technical hurdles. Why choose BioInCRO? I. Expert team with deep industry and academic experience II. Cutting-edge computational tools and resources III. Customized solutions tailored to your project's needs This offer is ideal for anyone at the forefront of biological research or in the early stages of a startup looking to make a significant impact in the field. 📅 Book your free consultation today! Spots are limited and will fill up quickly. Let’s collaborate to advance your research and achieve groundbreaking results. Contact us at experts@bioincro.com or visit our website to learn more and book your session. www.bioincro.com #Bioinformatics #Genomics #ComputationalBiology #FreeConsultation #ResearchInnovation #ScienceAndTechnology
BioInCRO | Contract Research Organisation
bioincro.com
To view or add a comment, sign in
-
Associate Professor, Chemistry @ Lincoln (from total synthesis to the total machine learning of molecules: Mception)
On the basis of the post below, are you striving to be an academic or a scientist?
Yes, “how long the H-index is” does matter in academia. But for science, it does NOT. Big discoveries are often made by people with small metrics. Examples are: 1. Katalin Karikó got ONLY ~300 citations/year in 2005 when she discovered the potential use of mRNA in therapeutics. 2. Andre Geim had ONLY ~1500 citations/year in 2004 when his team discovered graphene. 3. Frances Arnold got ONLY ~200 citations/year in 1993 when she demonstrated the directed evolution of enzymes. (And many others) 📍 In academia: 1. Faculty positions are much easier to get when you have strong metrics after PhD+postdoc. 2. Funding is much easier to get when you you have big metrics. It’s the case for most countries. 3. Strong postdocs prefer to join groups where professors have big profiles. 📍 In science: 1. Big discoveries do not care about the journal. Publishing in Nature/Science does not turn the study into a discovery. 2. Big ideas do not care about funding. Most discoveries were made without millions of $$$ in allocated budgets. 3. Great talents full of ideas can be found at any place. You don’t need to go to “top university” to find them. ❗️My point is simple: Academia ≠ science. #PhD #research #science
To view or add a comment, sign in
-
🧐 It may be common knowledge that proteins are essential for virtually every function in the human body, but did you know that advances in protein design and amino acid sequencing are paving the way for revolutionary new therapies and applications? Researchers are now able to design novel proteins with unprecedented precision, potentially transforming the landscape of medicine, biotechnology, and synthetic biology. 🧬 Designing novel proteins involves not just understanding their natural roles, but also engineering them to perform new and beneficial functions. This emerging field leverages cutting-edge technologies like CRISPR, machine learning, and computational biology to create proteins tailored to specific needs, offering new hope for treating diseases and developing innovative solutions in various industries. Organizations like 'The Institute for Protein Design' are also at the forefront of this rapidly developing area. By harnessing the power of protein and amino acid sequencing, you can also work to design a new world of proteins that will address 21st century challenges in medicine, energy and technology. 👉 Scroll to discover more about the fascinating world of protein design and its vast potential for the future! #GenomacInstitute #GenomacHoldings #Innovationinscience #Biotechnology #Proteindesign #Novelproteins #Proteinsequencing
To view or add a comment, sign in
-
Final Year Undergraduate at Wayamba University of Sri Lanka | Innovator | Sustainability Lover | Founder-SciLab Pvt Ltd |Founder of Miswalanka and Ecowave| Co-Founder of Banaroo Sausages | Data processing and Translator
Step by step guide for portien desingning, This will be a futuresting approach of bioinformatics that can create groundbreaking solutions for various problems.
🧐 It may be common knowledge that proteins are essential for virtually every function in the human body, but did you know that advances in protein design and amino acid sequencing are paving the way for revolutionary new therapies and applications? Researchers are now able to design novel proteins with unprecedented precision, potentially transforming the landscape of medicine, biotechnology, and synthetic biology. 🧬 Designing novel proteins involves not just understanding their natural roles, but also engineering them to perform new and beneficial functions. This emerging field leverages cutting-edge technologies like CRISPR, machine learning, and computational biology to create proteins tailored to specific needs, offering new hope for treating diseases and developing innovative solutions in various industries. Organizations like 'The Institute for Protein Design' are also at the forefront of this rapidly developing area. By harnessing the power of protein and amino acid sequencing, you can also work to design a new world of proteins that will address 21st century challenges in medicine, energy and technology. 👉 Scroll to discover more about the fascinating world of protein design and its vast potential for the future! #GenomacInstitute #GenomacHoldings #Innovationinscience #Biotechnology #Proteindesign #Novelproteins #Proteinsequencing
To view or add a comment, sign in
14,871 followers